Colossal Laboratories & Biosciences Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
174
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$163M
- Investors
-
54
Colossal Laboratories & Biosciences General Information
Description
Operator of a bioscience and genetic engineering company committed to building radical new technologies to advance the field of genomics. The company creates disruptive technologies for extinct species restoration, critically endangered species protection, and the repopulation of critical ecosystems that support the continuation of life on Earth and applies CRISPR technology for the purposes of species de-extinction, beginning with the woolly mammoth, enabling environmental organizations to restore Earth to a healthier state, while also solving for the future economies and biological necessities of the human condition.
Contact Information
Website
www.colossal.comCorporate Office
- 1401 Lavaca Street
- Unit 155
- Austin, TX 78701
- United States
Corporate Office
- 1401 Lavaca Street
- Unit 155
- Austin, TX 78701
- United States
Colossal Laboratories & Biosciences Timeline
Colossal Laboratories & Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 23-Jul-2024 | $163M | 00000 | 00.000 | Completed | Generating Revenue |
| 3. Accelerator/Incubator | 0000 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 19-Nov-2021 | $60M | $75M | 00000 | Completed | Generating Revenue |
| 1. Seed Round | 13-Sep-2021 | $15M | $15M | 00000 | Completed | Generating Revenue |
Colossal Laboratories & Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Seed-2 | 8,000,000 | $0.000001 | 6% | $1.21 | $1.21 | 1x | $1.21 | 2.25% |
| Seed-1 | 49,000,000 | $0.000001 | 6% | $0.17 | $0.17 | 1x | $0.17 | 13.78% |
Colossal Laboratories & Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
News about Colossal Laboratories & Biosciences
Dive into recent articles by PitchBook offering invaluable insights and context.
Colossal Laboratories & Biosciences Patents
Colossal Laboratories & Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240254508-A1 | Multi-genome editor construct and uses thereof | Pending | 27-Jan-2023 | 000000000 |
Colossal Laboratories & Biosciences Executive Team (13)
| Name | Title | Board Seat |
|---|---|---|
| Benjamin Lamm | Co-Founder & Chief Executive Officer | |
| Samuel Singer | Chief Financial Officer | |
| Adam Milne | Chief Operating Officer & Advisory Board | |
| Brian Beard JD | Co-Founder, Chief Legal Officer & Board Member | |
| Emily Castel | Chief Marketing Officer |
Colossal Laboratories & Biosciences Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Beard JD | Colossal Laboratories & Biosciences | Co-Founder, Chief Legal Officer & Board Member | 000 0000 |
Colossal Laboratories & Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Colossal Laboratories & Biosciences Investors (54)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amar Hussain | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Calm Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
| Corey Nobile | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Dana Sniezko | Angel (individual) | Minority | 000 0000 | 000000 0 |
| Elia Montanari | Angel (individual) | Minority | 000 0000 | 000000 0 |
Colossal Laboratories & Biosciences FAQs
-
When was Colossal Laboratories & Biosciences founded?
Colossal Laboratories & Biosciences was founded in 2021.
-
Who is the founder of Colossal Laboratories & Biosciences?
Benjamin Lamm, Brian Beard JD, Peter Phillips, Kent Wakeford JD, Andrew Busey, George Church Ph.D, and Vincent Cordero are the founders of Colossal Laboratories & Biosciences.
-
Who is the CEO of Colossal Laboratories & Biosciences?
Benjamin Lamm is the CEO of Colossal Laboratories & Biosciences.
-
Where is Colossal Laboratories & Biosciences headquartered?
Colossal Laboratories & Biosciences is headquartered in Austin, TX.
-
What is the size of Colossal Laboratories & Biosciences?
Colossal Laboratories & Biosciences has 174 total employees.
-
What industry is Colossal Laboratories & Biosciences in?
Colossal Laboratories & Biosciences’s primary industry is Biotechnology.
-
Is Colossal Laboratories & Biosciences a private or public company?
Colossal Laboratories & Biosciences is a Private company.
-
What is the current valuation of Colossal Laboratories & Biosciences?
The current valuation of Colossal Laboratories & Biosciences is 00.000.
-
What is Colossal Laboratories & Biosciences’s current revenue?
The current revenue for Colossal Laboratories & Biosciences is 000000.
-
How much funding has Colossal Laboratories & Biosciences raised over time?
Colossal Laboratories & Biosciences has raised $238M.
-
Who are Colossal Laboratories & Biosciences’s investors?
Amar Hussain, Calm Ventures, Corey Nobile, Dana Sniezko, and Elia Montanari are 5 of 54 investors who have invested in Colossal Laboratories & Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
